About Apogen
Driven by Quality,
Powered by Innovation
Corporate Profile
"Apogen... Driven by Quality & Innovation"

Apogen, a Quality driven pharmaceutical company with a strong matrix of capabilities is presently focusing on research, development, manufacturing & marketing of Ready to fill pre formulation intermediates of Immediate & Modified release pellets for a wide range of generic drug formulations in various Therapeutic segments.

Apogen stands out from the rest of the creed since Apogen, with its own talent pool further reinforced by a strong advisory board, offers various consultancy services for Pharmaceutical companies across the globe for collaborative business opportunities in all major arenas like, Formulation Research & Development, Co-development, Technology Transfer, Regulatory Registrations, Clinical Research, Contract Manufacturing, and many other related activities.

Having established itself in Indian market, Apogen now embarks on enhancing its share in global markets through its business associates.

Our Vision
To become one of the leading Indian Pharmaceutical companies in the Global market in developing novel drug delivery systems in acute & chronic therapeutic segments to help people lead healthier and Quality life.
Our Mission
Quality products for Quality Life through Innovation!

To provide better healthcare to the humanity with affordable drugs of uncompromised Quality and to pursue excellence in healthcare through innovation & empowered personnel

Our Objectives
We have set up our objectives to achieve our stated Vision & Mission:

Short Term
To identify conventional dosage forms having good potential from various therapeutic segments for attempting to formulate them in to NDDS at a later stage.
To Establish our position in Indian Market by adding new products & customers in our portfolio and to Strive for leadership in at least one therapeutic segment.
To enter International markets with special focus on Emerging Markets.
Medium Term
To develop & manufacture the identified & targeted drugs in NDDS form and commercialize them after seeking National & International regulatory approvals.
To Consolidate our presence in the Indian market and to consolidate our position as the leaders in at least one therapeutic segment.
To Establish & Spread our activities in the Emerging Markets and to evolve suitable strategies for entering into the markets of US & Europe.
Long Term
To become a vertically Integrated Pharma company focusing on development, manufacture & commercialization of APIs, Ready to fill pre formulation Intermediates, Direct compression granules & Formulations.
To consolidate our activities in the Emerging markets and strive to establish & consolidate leadership position in at least one or two therapeutic segments.
To gear up and enter USA, Europe & other highly regulated markets.

About Apogen